[Radiotherapy and targeted therapies in head and neck carcinomas and NSCLC]

A Bruna1, J Bourhis

  • 1Département de radiothérapie, institut Gustave-Roussy, 94800 Villejuif, France. abruna@oncorad.courlancy.fr

Bulletin Du Cancer
|May 13, 2009
PubMed

Insights

Targeted therapies combined with radiotherapy show promise for head and neck cancers and non-small cell lung cancer (NSCLC). Early results indicate improved survival with good tolerance, warranting further clinical trials.

Area of Science:

  • Oncology
  • Radiotherapy research

Background:

  • Targeted therapies are under intensive investigation for head and neck carcinomas and non-small cell lung cancer (NSCLC).
  • Combination of targeted therapies with radiotherapy presents a promising treatment strategy.

Purpose of the Study:

  • To review the current research and clinical results of targeted therapies in head and neck carcinomas and NSCLC.
  • To evaluate the efficacy and safety of combining targeted therapies with radiotherapy.

Main Methods:

  • Review of available clinical trial data and published results.
  • Focus on targeted therapies such as cetuximab (targeting EGF receptor) and bevacizumab (targeting angiogenesis).

Main Results:

  • Initial clinical results, primarily from head and neck carcinomas, show increased radiosensitivity.
  • Improved survival outcomes observed with a favorable tolerance profile.
  • Ongoing clinical trials are investigating combinations with standard chemo-radiotherapy.

Conclusions:

  • Combination of targeted therapies with radiotherapy is a promising approach for head and neck carcinomas and NSCLC.
  • Further clinical trials are necessary to confirm these encouraging results and optimize treatment protocols.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...